Project Grant R34DA063049
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,422,000.00 in funding to Kaiser Foundation Hospitals to develop and assess the feasibility and efficacy of a mobile health (mHealth) intervention for young adult women affected by sex trafficking. The project aims to address the significant health risks and lack of accessible services for this population, including increased rates of substance...
- This Project Grant award of $1,607,146.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a technology-based intervention to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The project, titled "Together Against Overdose: Community Developed Technology to Encourage Drug Checking, Distribution of Harm Reduction Supplies, and...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $677,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant, awarded on June 15, 2025, supports the development and testing of the "Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention" for implementation in syringe service programs. The project aims to engage women with experiences of...
- This $375,000 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to evaluate the impact of a status-neutral, person-centric intervention called the "Blue Shed" on HIV transmission and outcomes among people who inject drugs (PWID) in New Delhi, India. The project has three key objectives: Assess the direct impact of the Blue Shed intervention on HIV incidence, viral suppression, and mortality among PWID...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is for $764,165 to develop and evaluate the CONNECT program. The CONNECT program aims to increase HIV and substance use care among survivors of sexual trafficking through a digital intervention delivered via street medicine. The award will fund an open trial (N=12) and a randomized pilot trial (N=60) to assess the feasibility, acceptability, and...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $4,725,000 to the University of California, Los Angeles (UCLA) to develop new dissemination strategies that improve the availability and user-friendliness of research on preventing HIV transmission and effectively treating substance use disorders (SUDs). The project aims to mitigate policy-level barriers and upstream barriers that hinder access...
- This Project Grant award of $1,344,412 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to increase HIV and substance misuse prevention and treatment among adolescent and young adult (AYA) sexual violence survivors. The University of Texas Health Science Center at Houston (UTHealth) will tailor existing Sexual Assault Nurse Examiner (SANE) services to include same-day HIV prophylaxis and substance use prevention, using...
- This federal Project Grant award of $1,948,634.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and test a smartphone-based mobile health (mHealth) intervention to reduce overdose risk among people who engage in polysubstance use. The study will build on previous research findings on polysubstance use patterns to develop the "OD-CHESS" intervention by adapting an existing substance use disorder...
- This $304,215 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and validation of a novel software platform for decentralized clinical trials in substance use disorder (SUD) research. The software will incorporate large language models to address challenges in SUD clinical trials, such as participant diversity, recruitment, and retention. The award recipient, Carina Medical LLC, is a...
This $246,012 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will assess whether a digital, survivor-crowdsourced intervention can increase HIV/STI/HCV testing and overdose prevention kit utilization among survivors of sex trafficking living in New York City. The project aims to: 1) develop crowdsourced digital messages to promote HIV/STI/HCV testing and overdose prevention service utilization, 2) compare the survivor-crowdsourced intervention to existing public health messaging in a randomized controlled trial, and 3) assess the reach, effectiveness, adoption, implementation, and maintenance outcomes. This work will result in a digital crowdsourced intervention to increase critical healthcare service utilization among this high-risk population facing substantial barriers to care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/19/25 | ||
| Not listed | $246.0k | 8/28/25 |